Immediate Impact

63 standout
Sub-graph 1 of 23

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Biliary tract cancer
2021 Standout
2 intermediate papers

Works of J. J. Zarba being referenced

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
1998
554 Demonstrated efficiency of 5fluorouracil (5FU) continuous infusion (CI) and cisplatin (P) in patients with advanced biliary tract carcinoma
1995

Author Peers

Author Last Decade Papers Cites
J. J. Zarba 154 121 19 159 10 231
K.R. Durrant 129 102 29 85 13 277
Neelofur Ahmad 191 68 28 167 15 261
Chimela Ohaji 78 41 8 62 8 159
T.C. Kok 202 82 11 79 12 281
Michelle Marcovitz 81 72 43 64 6 152
Kalpana Devaraj 62 36 11 64 8 210
Paul R. Timmer 51 114 72 108 10 238
C Antonescu 84 160 4 77 11 253
Babak N. Kalantari 86 33 3 168 10 265
Jeffrey P. B. M. Braak 75 194 40 124 11 268

All Works

Loading papers...

Rankless by CCL
2026